Cencora opened higher at $336.79, compared with its previous close of $330.53. In the last trading session, the stock traded between $332.29 and $340.19. It showed an upward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Cencora is now worth
$ 234.70
giving a profit of
$ 134.70 (134.70%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 13 Analysts
Buy
76.92%
Hold
23.08%
Sell
0%
Markets Today
Today's Change
+$3.82 (+1.16%)
Day High
$340.19
Day Low
$332.29
Day Open
$336.79
Prev Close
$330.53
Volume
5,18,766
1W Return
-1.21%
1M Return
8.73%
3M Return
4.97%
6M Return
7.36%
1Y Return
0.35%
Fundamentals
Market Cap ($ Mn)
63,803
PE Ratio
23.91
PB Ratio
20.14
PEG Ratio
4.62
ROE
145.88%
ROCE
15.18%
EPS (TTM)
$4.00
Investment Returns
1 Week
-1.21%
1 Month
8.73%
3 Months
4.97%
6 Months
7.36%
9 Months
-5.04%
Financials
Quarterly
All values in $ Mn
81.5K
Dec 24
75.5K
Mar 25
80.7K
Jun 25
83.7K
Sep 25
85.9K
Dec 25
84.8K
Jun 26
Updates
21Oct
Cencora delivers 22.6% annualized return, beating market by 11.54%
Cencora achieved a 22.6% average annual return over the last five years. The stock outperformed the market by 11.54% on an annualized basis. A $100 investment from five years ago is now valued at $277.75. Current market capitalization stands at $64.88 billion with a share price of $340.57.
9 days ago
21Oct
Cencora to acquire remaining stake in American Oncology Network for $2.4B
Cencora acquires remaining equity in American Oncology Network at a $2.4 billion enterprise value. Deal includes $2.3 billion paid at closing and up to $100 million in contingent value rights. Cencora expects to pay approximately $1.7 billion cash if 25% equity rollover is utilized. Ownership stake in AON increases from approximately 4% to 75%.
9 days ago
20Oct
Argus Research raises Cencora price target to $380
Argus Research raised the price target for Cencora to $380. The previous price target was $340. The analyst maintained a Buy rating on the stock. David Toung is the analyst responsible for the revision.
10 days ago
16Oct
UBS maintains Buy on Cencora, lowers price target to $400
UBS maintains Buy rating on Cencora. Price target lowered from $430 to $400. Analyst Kevin Caliendo issued the update.
13 days ago
12Sep
Cencora stock returns $6,428 on $1,000 invested over 10 years
Cencora stock generated an average annual return of 20.35% over the last decade. A $1,000 investment made 10 years ago is now worth $6,428.83. The stock outperformed the market by 6.79% on an annualized basis. Current market capitalization stands at $61.36 billion.
1mo ago
8Sep
RBC Capital reiterates Sector Perform on Cencora, holds $330 target
RBC Capital reiterates Sector Perform rating on Cencora (NYSE: COR). Price target remains unchanged at $330 per share. Analyst Ryan Halsted maintains previous valuation estimate.
